The global Endocrine Testing Market is currently valued at US$ 2536.7 million and is expected to grow at an 8.5% CAGR. With the rising prevalence of diabetes and the ageing population, the market is expected to reach US$ 5735 million by 2032. The growing prevalence of endocrine disorders and the advancement of diagnostic techniques have skyrocketed in …